BASLER AG (BSL.DE) Fundamental Analysis & Valuation

FRA:BSL • DE0005102008

Current stock price

14.52 EUR
-0.8 (-5.22%)
Last:

This BSL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BSL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BSL was profitable.
  • BSL had a positive operating cash flow in the past year.
  • In multiple years BSL reported negative net income over the last 5 years.
  • Each year in the past 5 years BSL had a positive operating cash flow.
BSL.DE Yearly Net Income VS EBIT VS OCF VS FCFBSL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

  • BSL has a Return On Assets (1.72%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 2.96%, BSL perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.45%, BSL is in line with its industry, outperforming 47.06% of the companies in the same industry.
Industry RankSector Rank
ROA 1.72%
ROE 2.96%
ROIC 3.45%
ROA(3y)-1.08%
ROA(5y)2.8%
ROE(3y)-1.96%
ROE(5y)4.7%
ROIC(3y)N/A
ROIC(5y)N/A
BSL.DE Yearly ROA, ROE, ROICBSL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

  • BSL has a Profit Margin (1.87%) which is comparable to the rest of the industry.
  • Looking at the Operating Margin, with a value of 4.37%, BSL is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 47.17%, BSL is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
  • BSL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.37%
PM (TTM) 1.87%
GM 47.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.66%
GM growth 5Y-2.2%
BSL.DE Yearly Profit, Operating, Gross MarginsBSL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BSL.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BSL is destroying value.
  • BSL has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BSL has been increased compared to 5 years ago.
  • Compared to 1 year ago, BSL has an improved debt to assets ratio.
BSL.DE Yearly Shares OutstandingBSL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BSL.DE Yearly Total Debt VS Total AssetsBSL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • BSL has an Altman-Z score of 4.91. This indicates that BSL is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.91, BSL belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
  • The Debt to FCF ratio of BSL is 5.31, which is a neutral value as it means it would take BSL, 5.31 years of fcf income to pay off all of its debts.
  • BSL's Debt to FCF ratio of 5.31 is fine compared to the rest of the industry. BSL outperforms 60.78% of its industry peers.
  • BSL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • BSL has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.31
Altman-Z 4.91
ROIC/WACC0.52
WACC6.64%
BSL.DE Yearly LT Debt VS Equity VS FCFBSL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 2.44 indicates that BSL has no problem at all paying its short term obligations.
  • BSL has a Current ratio of 2.44. This is amongst the best in the industry. BSL outperforms 80.39% of its industry peers.
  • BSL has a Quick Ratio of 1.71. This is a normal value and indicates that BSL is financially healthy and should not expect problems in meeting its short term obligations.
  • BSL has a Quick ratio of 1.71. This is amongst the best in the industry. BSL outperforms 84.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.71
BSL.DE Yearly Current Assets VS Current LiabilitesBSL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BSL.DE Growth Analysis

3.1 Past

  • BSL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 233.50%, which is quite impressive.
  • The Revenue has grown by 17.62% in the past year. This is quite good.
  • Measured over the past years, BSL shows a small growth in Revenue. The Revenue has been growing by 2.74% on average per year.
EPS 1Y (TTM)233.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%239.42%
Revenue 1Y (TTM)17.62%
Revenue growth 3Y-4.88%
Revenue growth 5Y2.74%
Sales Q2Q%29.52%

3.2 Future

  • The Earnings Per Share is expected to grow by 118.07% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 12.43% on average over the next years. This is quite good.
EPS Next Y548.14%
EPS Next 2Y186.74%
EPS Next 3Y118.07%
EPS Next 5YN/A
Revenue Next Year24.51%
Revenue Next 2Y17.24%
Revenue Next 3Y15.68%
Revenue Next 5Y12.43%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BSL.DE Yearly Revenue VS EstimatesBSL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
BSL.DE Yearly EPS VS EstimatesBSL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

3

4. BSL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • BSL is valuated quite expensively with a Price/Earnings ratio of 111.69.
  • BSL's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 25.79, BSL is valued quite expensively.
  • BSL is valuated quite expensively with a Price/Forward Earnings ratio of 25.67.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BSL is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, BSL is valued at the same level.
Industry RankSector Rank
PE 111.69
Fwd PE 25.67
BSL.DE Price Earnings VS Forward Price EarningsBSL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • BSL's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BSL indicates a slightly more expensive valuation: BSL is more expensive than 64.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.63
EV/EBITDA 18.11
BSL.DE Per share dataBSL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BSL's earnings are expected to grow with 118.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y186.74%
EPS Next 3Y118.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. BSL.DE Dividend Analysis

5.1 Amount

  • BSL has a Yearly Dividend Yield of 1.52%. Purely for dividend investing, there may be better candidates out there.
  • BSL's Dividend Yield is a higher than the industry average which is at 1.65.
  • Compared to the average S&P500 Dividend Yield of 1.91, BSL is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BSL.DE Yearly Dividends per shareBSL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y186.74%
EPS Next 3Y118.07%
BSL.DE Yearly Income VS Free CF VS DividendBSL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

More info and screens

Find the best dividend stocksShow peers with best dividend

BSL.DE Fundamentals: All Metrics, Ratios and Statistics

BASLER AG

FRA:BSL (3/19/2026, 4:40:09 PM)

14.52

-0.8 (-5.22%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-06
Earnings (Next)03-26
Inst Owners23.64%
Inst Owner ChangeN/A
Ins Owners3.96%
Ins Owner ChangeN/A
Market Cap457.38M
Revenue(TTM)213.91M
Net Income(TTM)4.00M
Analysts80
Price Target21.59 (48.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 111.69
Fwd PE 25.67
P/S 2.14
P/FCF 36.63
P/OCF 20.84
P/B 3.39
P/tB 10.12
EV/EBITDA 18.11
EPS(TTM)0.13
EY0.9%
EPS(NY)0.57
Fwd EY3.9%
FCF(TTM)0.4
FCFY2.73%
OCF(TTM)0.7
OCFY4.8%
SpS6.79
BVpS4.28
TBVpS1.43
PEG (NY)0.2
PEG (5Y)N/A
Graham Number3.54
Profitability
Industry RankSector Rank
ROA 1.72%
ROE 2.96%
ROCE 4.9%
ROIC 3.45%
ROICexc 4.04%
ROICexgc 8.99%
OM 4.37%
PM (TTM) 1.87%
GM 47.17%
FCFM 5.84%
ROA(3y)-1.08%
ROA(5y)2.8%
ROE(3y)-1.96%
ROE(5y)4.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.66%
GM growth 5Y-2.2%
F-Score7
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.31
Debt/EBITDA 1.87
Cap/Depr 49.28%
Cap/Sales 4.42%
Interest Coverage 5.4
Cash Conversion 76.85%
Profit Quality 312.51%
Current Ratio 2.44
Quick Ratio 1.71
Altman-Z 4.91
F-Score7
WACC6.64%
ROIC/WACC0.52
Cap/Depr(3y)94.94%
Cap/Depr(5y)97.08%
Cap/Sales(3y)7.69%
Cap/Sales(5y)7.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)233.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%239.42%
EPS Next Y548.14%
EPS Next 2Y186.74%
EPS Next 3Y118.07%
EPS Next 5YN/A
Revenue 1Y (TTM)17.62%
Revenue growth 3Y-4.88%
Revenue growth 5Y2.74%
Sales Q2Q%29.52%
Revenue Next Year24.51%
Revenue Next 2Y17.24%
Revenue Next 3Y15.68%
Revenue Next 5Y12.43%
EBIT growth 1Y183%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year535.87%
EBIT Next 3Y105.83%
EBIT Next 5YN/A
FCF growth 1Y224.54%
FCF growth 3Y-20.46%
FCF growth 5YN/A
OCF growth 1Y124.37%
OCF growth 3Y-16.7%
OCF growth 5Y-9.96%

BASLER AG / BSL.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BASLER AG?

ChartMill assigns a fundamental rating of 5 / 10 to BSL.DE.


Can you provide the valuation status for BASLER AG?

ChartMill assigns a valuation rating of 3 / 10 to BASLER AG (BSL.DE). This can be considered as Overvalued.


Can you provide the profitability details for BASLER AG?

BASLER AG (BSL.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for BSL stock?

The financial health rating of BASLER AG (BSL.DE) is 7 / 10.


What is the expected EPS growth for BASLER AG (BSL.DE) stock?

The Earnings per Share (EPS) of BASLER AG (BSL.DE) is expected to grow by 548.14% in the next year.